On Tuesday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $62.09.
Wedbush initiated coverage on shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in a research note released on Tuesday morning. The firm issued an outperform rating on the stock.
Oxford Immunotec Global PLC (NASDAQ:OXFD) in last trading activity increased 6.10% to close at $14.08. Company weekly performance is -0.64% while its quarterly performance stands at 5.00%. Oxford Immunotec Global PLC (NASDAQ:OXFD) is -33.74% away from its 52 week high. Oxford Immunotec Global PLC (NASDAQ:OXFD) announced the availability in the United States of a new test that measures the strength of a patient’s cellular immune response to cytomegalovirus (CMV). This T-SPOT®.CMV test is available as a Laboratory Developed Test from the Company’s CLIA-certified and CAP accredited service laboratory.
On last trading day Supertel Hospitality, Inc. (NASDAQ:SPPR) increased 5.42% to close at $1.75. Its volatility for the week is 12.97% while volatility for the month is 11.06%. SPPR’s sales growth for past 5 years was -4.60% and its EPS growth for past 5 years was -3.80%. Supertel Hospitality, Inc. (NASDAQ:SPPR) monthly performance is 15.13%. On 23 March, Supertel Hospitality, Inc. (NASDAQ:SPPR) announced its results for the fourth quarter and year ended December 31, 2014. Revenue from continuing operations in the fourth quarter was $13.2 million, an increase of 9.7 percent over the same 2013 period and $57.4 million for the full year, an increase of 6.7 percent over the prior year.
On Tuesday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $18.78. Epizyme, Inc. (NASDAQ:EPZM) announced that data from its preclinical pipeline will be presented during the American Association for Cancer Research (AACR) Annual Meeting, to be held April 18-25 in Philadelphia, Pa.
On last trading day Gevo, Inc. (NASDAQ:GEVO) moved down -5.37% to close at $0.20. Its volatility for the week is 12.16% while volatility for the month is 10.51%. GEVO’s sales growth for past 5 years was 109.60% and its EPS growth for past 5 years was 8.80%. Gevo, Inc. (NASDAQ:GEVO) monthly performance is -22.69%. On 26 March, Gevo, Inc. (NASDAQ:GEVO) announced its financial results for the three months ended December 31, 2014. The company reported a non-cash loss of $0.2 million during the fourth quarter of 2014, as compared to a non-cash loss of $2.4 million during the same period in 2013,